Sionna Therapeutics, Inc. Common Stock (SION) — Defensive Interval Ratio
Sionna Therapeutics, Inc. Common Stock (SION) has a Defensive Interval Ratio of 5530 days as of December 2025. Defensive assets of $177.43 Million (cash $-, short-term investments $177.43 Million, receivables $-) cover 5530 days of daily cash needs of $32.09K/day. See SION working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Sionna Therapeutics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Sionna Therapeutics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 5530 days, meaning defensive assets of $177.43 Million can fund 5530 days of operations without new revenue. See Sionna Therapeutics, Inc. Common Stock (SION) balance sheet quality index to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Sionna Therapeutics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Sionna Therapeutics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Sionna Therapeutics, Inc. Common Stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 5530 days | $177.43 Million | $32.09K/day | $- | $177.43 Million | ▲ +1685 days |
| 2024 | 3844 days | $109.75 Million | $28.55K/day | $- | $109.75 Million | ▲ +3844 days |
| 2023 | 0 days | $0.00 | $22.02K/day | $- | $0.00 | ▼ -1228 days |
| 2022 | 1228 days | $27.77 Million | $22.61K/day | $- | $27.77 Million | — |